Wellcome Trust And Merck & Co., Inc. Launch First of Its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries
LONDON & WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries.